ALB-03

N/A

Report date: 2024/08/21 14:09:33

Base Information

Drug NameALB-03
Drug Alias NameALB-03
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCalnexin inhibitors
TargetsCalnexin
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlbatroz Therapeutics Pte Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A